Metoprolol tartrate/seabuckthorn oil nanoemulsion antihypertensive drug

An anti-hypertensive, tartaric acid technology, applied in the field of medicine, can solve the problems of unutilized drug efficacy, slow drug dissolution rate, poor bioavailability, etc., and achieve the goal of improving bioavailability, promoting gastrointestinal absorption, and taking convenience Effect

Inactive Publication Date: 2012-10-03
NORTHWEST A & F UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are antihypertensive drugs such as metoprolol tartrate tablets on the market, and the use of seabuckthorn oil is also available. Although it can be absorbed from the gastrointestinal tract after oral administration, the absorption is not complete. In addition, the dissolution rate of the drug is slow and the bioavailability is poor. Coupled with the slow action of metoprolol tartrate, the efficacy of metoprolol tartrate and seabuckthorn oil cannot be utilized

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
particle sizeaaaaaaaaaa
diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses an oil-in-water type metoprolol tartrate / seabuckthorn oil nanoemulsion antihypertensive drug which is characterized in that the nanoemulsion antihypertensive drug has particle size of 30.1-71.8 nm. The drug comprises the following raw materials by weight: 1-20% of metoprolol tartrate, 15-40% of surfactant, 1-25% of co-surfactant, 1-25% of seabuckthorn oil, and the balance of distilled water. The sum of the mass percent of the raw materials is 100%. The nanoemulsion preparation organically combines water-soluble drug metoprolol tartrate and lipid-soluble seabuckthorn oil, to improve dissolution and penetration abilities of seabuckthorn oil, and improve stability and medicinal effect of metoprolol tartrate. The metoprolol tartrate / seabuckthorn oil nanoemulsion combines advantages of metoprolol tartrate and seabuckthorn oil to obviously improve antihypertensive effect, prolong half life of drug, and reduce administration times.

Description

Technical field [0001] The invention belongs to the field of medicine, and relates to a new dosage form of antihypertensive drug metoprolol tartrate and sea buckthorn oil, in particular to a nanoemulsion antihypertensive medicine metoprolol tartrate and sea buckthorn oil. Background technique [0002] Metoprolol Tartaric Acid, full name: 1-isopropylamino-3-[p-(2-methoxyethyl)phenoxy]-2-propanol L(+)-tartrate, molecular formula : (C 15 H 25 NO 3 )2·C 4 H 6 O 6 , Molecular weight: 684.8. This product is a β-receptor blocker with weak membrane stabilization and no endogenous sympathomimetic activity. It has a large selective effect on the β-receptors of the heart. Β on vascular and bronchial smooth muscle at larger doses 2 The receptor also has a role. It can slow down the atrioventricular conduction and slow down the sinus heart rate. It can also slow down the heart rate, reduce cardiac output, and reduce systolic blood pressure. This drug belongs to category 2A, that is, β w...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/185A61K47/44A61K47/34A61K47/26A61K9/107A61P9/12A61K31/205A61K31/138
Inventor 欧阳五庆孙江宏杜娟
Owner NORTHWEST A & F UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products